Abstract

To the Editor: Many clinicians have observed that acceleration of body surface area (BSA) involvement in mycosis fungoides correlates with disease progression.1 The goal of this study is to quantify acceleration and determine if this parameter can predict progression and/or assure patients that they are unlikely to progress.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call